Innovative technologies and services
for pharma & biotech
HWI group offers a broad technological, analytical and regulatory portfolio for the development, manufacturing and analytical testing of medicinal products with small and large molecules.
Laboratory services with
a focus on product development
Our strength is the development and validation of analytical methods, batch release and stability studies, testing concepts for impurities and in solving complex analytical issues.
Formulation development for
small and large molecules
The HWI technology platform offers innovative solutions for fast and cost-efficient development of parenteral, intranasal and oral formulations for small and large active ingredients.
Digitalised service concepts
We take over operative activities and advise on pharmacovigilance in the life cycle and clinical trials of medicinal products and medical devices. We digitalise your PV processes and optimise your established systems.
Vigilance & Quality
The active pharmaceutical ingredient (API) is at the heart of our risk-based development. Its properties have a critical influence on the quality of the product. In our ultra-modern clean rooms we can also work with highly potent active ingredients. By using statistical design of experiment (DoE) we offer an efficient pharmaceutical development that completely fulfils the requirements of quality by design.
Monday - Friday